These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 2757551)

  • 1. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL; Salisbury MA; Ward DA
    Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine.
    Kaswan RL; Salisbury MA
    Vet Clin North Am Small Anim Pract; 1990 May; 20(3):583-613. PubMed ID: 2194349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A; English RV; Nadelstein B
    Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV; Abrams KL
    J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
    J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
    Chen T; Powell CC
    Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
    Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cyclosporine therapy for keratoconjunctivitis sicca in dogs.
    Kern TJ
    Cornell Vet; 1989 Jul; 79(3):207-9. PubMed ID: 2752756
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I; Szadkowski M
    Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of topical aqueous sirolimus on tear production in normal dogs and dogs with refractory dry eye.
    Spatola R; Nadelstein B; Berdoulay A; English RV
    Vet Ophthalmol; 2018 May; 21(3):255-263. PubMed ID: 28972684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I
    Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C; Celik I; Alkan F; Erol M; Sur E
    Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
    Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
    Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
    de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
    Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
    Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
    Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
    J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tear film osmolarity using the TearLab
    Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
    Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
    Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
    Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.